Re-treatment With Adjuvant Radioactive Iodine Does Not Improve Recurrence-Free Survival of Patients With Differentiated Thyroid Cancer

Re-treatment With Adjuvant Radioactive Iodine Does Not Improve Recurrence-Free Survival of Patients With Differentiated Thyroid Cancer

Introduction: Loco regional persistence or recurrence of differentiated thyroid cancer (DTC) is frequent despite initial thyroidectomy and radioactive iodine therapy (RAI). The aim of this study was to analyze the impact of a complementary adjuvant RAI (Ad-RAI) on disease recurrence following re-ope...

Full description

Bibliographic Details
Main Authors: Clément Bouvet, Bertrand Barres, Fabrice Kwiatkowski, Marie Batisse-Lignier, Meryem Chafai El Alaoui, Philippe Kauffmann, Florent Cachin, Igor Tauveron, Antony Kelly, Salwan Maqdasy
Format: Article
Language:English
Published: Frontiers Media S.A. 2019-09-01
Series:Frontiers in Endocrinology
Subjects:
differentiated thyroid cancer
adjuvant RAI
recurrence
persistence
re-operation
re-treatment
Online Access:https://www.frontiersin.org/article/10.3389/fendo.2019.00671/full

Internet

https://www.frontiersin.org/article/10.3389/fendo.2019.00671/full

Similar Items